Reducing TRAF4 can inhibit cancer cell proliferation, invasion and metastasis by downregulating the AKT signaling pathway, inhibiting the NF-κB pathway and engaging in RSK4 interactions (43). The gene discussed is AKT1; the disease is cancer.